Chronic activation of NF-κB in cancer assists in the onset; progression of tumor; metastasis; and resistance towards chemotherapeutics by augmenting the expression of various growth factors, pro-inflammatory cytokines, chemokines, and anti-apoptotic factors [17,18,19,20]. The gene discussed is NFKB1; the disease is cancer.